Scientific cooperation between Ghent and FAGG

01 January 2007 → 31 December 2009
Federal funding: various
Research disciplines
  • Medical and health sciences
    • Biomarker discovery and evaluation
    • Drug discovery and development
    • Medicinal products
    • Pharmaceutics
    • Pharmacognosy and phytochemistry
    • Pharmacology
    • Pharmacotherapy
    • Toxicology and toxinology
    • Other pharmaceutical sciences
Project description

This collaboration aims to commitments to realize the FAMHP has compared the EMEA, the European Agency for the registration of medicines. The FAMHP CHMP gives its members the task to be rapporteur for some drugs. Zo''n rapporteur ship involves a number of tasks that can be divided broadly into quality, toxicology, and efficacy and safety. The quality section is an assessment be done with the original application for registration or an application for a change in manufacture, control methods and shelf-life of the active ingredient or finished product, Belgian CHMP members rapporteur on several cases in which the drug bio-technology are produced. As Prof, DEFORCE is a biotechnology expert, FAMHP wants to make use of his expertise to the above to fulfill the tasks mentioned above.